EU Medicines Agency auf Twitter: "EMA has approved additional manufacturing sites for the production of the BioNTech/Pfizer #COVID19vaccine. These two sites located in Germany will provide up to 50 million additional doses in 2021 πππ #PublicHealth #HealthUnion πhttps://t.co/plP6rglnE7 https://t.co/viikyoADGJ" / Twitter
Genug fΓΌr alle daΒ°
https://twitter.com/EMA_News/status/1435993283826749442
EMA has approved additional manufacturing sites for the production of the BioNTech/Pfizer #COVID19vaccine.
— EU Medicines Agency (@EMA_News) September 9, 2021
These two sites located in Germany will provide up to 50 million additional doses in 2021 πππ#PublicHealth #HealthUnion
πhttps://t.co/plP6rglnE7 pic.twitter.com/viikyoADGJ
5 Likes
2 Shares